Introduction For some manufacturers, launching in the Middle East and North Africa (MENA) is fraught...
Read moreWith respects to pricing and reimbursement, the societies reportedly call for the criteria that led ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreIntroduction Health Technology Assessment (HTA) implementation has been historically slow in Asia co...
Read moreA short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...
Read moreIntroduction: Brazil is a market of 210 million people Brazil is the largest country in South Americ...
Read moreTwo NICE teams (NICE International and the Science Policy and Research Programme) will act as key en...
Read moreBeyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...
Read moreIn December 2021, China once again updated its National Reimbursed Drugs List (NRDL).
Read moreOn 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...
Read more